Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.39 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.39 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30511373 | 0.95 | LMNA (0.52) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL11787069 | 0.92 | MAPT (0.46) | LMNAALDH1A1MAPTFFAR4 | |
| SCHEMBL1906895 | 0.92 | LMNA (0.40) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL18523300 | 0.90 | LMNA (0.39) | LMNAPHF8KDM2ACHRNB2CHRNB4 | |
| SCHEMBL23521354 | 0.90 | MAPT (0.49) | LMNAMAPTFFAR4 | |
| SCHEMBL11194848 | 0.90 | MAPT (0.49) | LMNAMAPTFFAR4 | |
| SCHEMBL15660116 | 0.90 | MAPT (0.49) | LMNAMAPTFFAR4 | |
| SCHEMBL15657593 | 0.90 | MAPT (0.49) | LMNAMAPTFFAR4 | |
| SCHEMBL23521355 | 0.90 | MAPT (0.49) | LMNAMAPTFFAR4 | |
| SCHEMBL15659443 | 0.90 | MAPT (0.49) | LMNAMAPTFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 548 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702077-A1 | BRANCHED POLYESTER COMPOSITION FOR POWDER COATINGS | Arkema Quimica SAU (ES) | 2026-03-04 | — | — | EP | claimed |
| US-12552959-B2 | Aqueous coating composition for corrosion protection | ALLNEX AUSTRIA GMBH (AT) | 2026-02-17 | — | — | US | claimed |
| WO-2024223770-A1 | BRANCHED POLYESTER COMPOSITION FOR POWDER COATINGS | ARKEMA QUIMICA SAU (ES) | 2024-10-31 | — | — | WO | claimed |
| EP-4455184-A1 | BRANCHED POLYESTER COMPOSITION FOR POWDER COATINGS | Arkema Quimica SAU (ES) | 2024-10-30 | — | — | EP | claimed |
| US-20240084167-A1 | AQUEOUS COATING COMPOSITION FOR CORROSION PROTECTION | ALLNEX AUSTRIA GMBH (AT) | 2024-03-14 | — | — | US | claimed |
| EP-3753991-B1 | AQUEOUS COATING MATERIAL COMPOSITION | TOYO SEIKAN GROUP HOLDINGS LTD (JP) | 2024-03-06 | — | — | EP | claimed |
| EP-4330335-A1 | AQUEOUS COATING COMPOSITION FOR CORROSION PROTECTION | Allnex Austria GmbH (AT) | 2024-03-06 | — | — | EP | claimed |
| CN-115353853-B | Double-component polyurethane adhesive and preparation method and application thereof | 杭州之江有机硅化工有限公司 | 2023-08-01 | — | — | CN | claimed |
| US-20230159786-A1 | USE OF COATING COMPOSITIONS FOR MAKING A SUBSTRATE FROST RESISTANT, COMPOSITIONS AND METHODS USEFUL THEREFOR | SOLVAY SA (BE) | 2023-05-25 | — | — | US | claimed |
| US-11602768-B2 | Acrylic polymers and compositions containing such polymers | SWIMC, LLC (US) | 2023-03-14 | — | — | US | claimed |
| EP-1280010-B1 | Crosslinked binder polymers for electrostatographic toners and toners formed therefrom | EASTMAN KODAK CO (US) | 2008-08-27 | — | — | EP | claimed |
| US-20070259989-A1 | Ink jet ink, ink set and method of printing | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-11-08 | — | — | US | claimed |
| US-7259115-B2 | Curable extruded adhesive laminate system for manufacturing collapsible structures | COOLEY, INCORPORATED (US) | 2007-08-21 | — | — | US | claimed |
| US-20050112971-A1 | Curable extruded adhesive laminate system for manufacturing collapsible structures | K2 BUYER, INC. | 2005-05-26 | — | — | US | claimed |
| US-6861192-B2 | Crosslinked binder polymers for electrostatographic toners and toners formed therefrom | EASTMAN KODAK COMPANY (US) | 2005-03-01 | — | — | US | claimed |
| US-6849705-B2 | Bifunctional polyaddition compounds as crosslinkers for polyurethane powder coatings | DEGUSSA AG (DE) | 2005-02-01 | — | — | US | claimed |
| US-20040014855-A1 | Transparent or pigmented powder coatings based on certain carboxyl-containing polyesters with hydroxyalkylamides and use thereof | DEGUSSA AG (DE) | 2004-01-22 | — | — | US | claimed |
| US-20030212239-A1 | Bifunctional polyaddition compounds as crosslinkers for polyurethane powder coatings | DEGUSSA AG (DE) | 2003-11-13 | — | — | US | claimed |
| US-20030069368-A1 | Crosslinked binder polymers for electrostatographic toners and toners formed therefrom | BANK OF AMERICA, N.A., AS AGENT | 2003-04-10 | — | — | US | claimed |
| EP-1280010-A2 | Crosslinked binder polymers for electrostatographic toners and toners formed therefrom | Heidelberger Druckmaschinen Aktiengesellschaft (DE) | 2003-01-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552959-B2 | Aqueous coating composition for corrosion protection | ADH1A, ADH1C, TET1 | LMNA 1900/4885KDM4C 315/4885KDM4A 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.